arrow
G

Grace Gallagher

Memorial Sloan Kettering Cancer Center
H指数:6
被引数:159

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Initial chemotherapy dose reductions and subsequent treatment delivery in stage I–IIIA breast cancer

I期至IIIA期乳腺癌初始化疗剂量减少及后续治疗实施

Cancer
IF5.1
2026-02-240
PRE
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer

年龄与Ⅰ期-ⅢA期乳腺癌女性化疗剂量减量的关联

2025-11-010
PRE
Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I–IIIA breast cancer

与常规方案相比,剂量密集化疗在I~IIIA期乳腺癌女性患者中的相关患者特征

2025-07-060
PRE
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study
2025-02-010
PRE
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system

在综合医疗保健提供系统中,在i-iiia期乳腺癌中使用NCCN指南化疗方案的前景

2024-08-160
PRE
Patient Characteristics Associated with Intended Nonguideline Chemotherapy in Women with Stage I to IIIA Breast Cancer
2024-07-251
PRE
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer
2024-07-060
PRE
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019
2024-06-131
OAAI
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer
2024-04-014
PRE
Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study
THORAX
IF7.7
2020-06-0114
OAAI